Managing chronic disease in Ireland: Hospital admission rates and clinical outcomes in a large ulcerative colitis population

Irish Journal of Medical Science

Volumn 181, Issue 1, 2012, Pages 65-71

  Desmond, A N ^a   Shanahan, F ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Colectomy; Inflammatory bowel disease; Infliximab; Thiopurines; Ulcerative colitis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; HYDROCORTISONE; INFLIXIMAB; MERCAPTOPURINE; PREDNISOLONE;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ACUTE PANCREATITIS; ADULT; AGED; APHTHOUS ULCER; ARTHRALGIA; ARTICLE; AVASCULAR NECROSIS; BONE MARROW SUPPRESSION; CAUSE OF DEATH; CHICKENPOX; CHOLANGITIS; COLITIS; COLON RESECTION; CORTICOSTEROID THERAPY; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG USE; FATIGUE; FEMALE; FOLLOW UP; GENDER; HERPES ZOSTER; HOSPITAL ADMISSION; HUMAN; IRELAND; ISCHEMIC HEART DISEASE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; METASTASIS; MYALGIA; NAUSEA AND VOMITING; OLIGOSPERMIA; OUTCOME ASSESSMENT; OUTPATIENT CARE; PANCOLITIS; PNEUMONIA; PREDICTION; PROSTATE CARCINOMA; RASH; SIDE EFFECT; SMOKING; TERTIARY HEALTH CARE; ULCERATIVE COLITIS; VIRUS HEPATITIS;

6-MERCAPTOPURINE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; AZATHIOPRINE; CHILD; CHILD, PRESCHOOL; COLECTOMY; COLITIS, ULCERATIVE; FEMALE; HOSPITALIZATION; HUMANS; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENTS; INFANT; IRELAND; MALE; MIDDLE AGED; PREDNISOLONE; YOUNG ADULT;

EID: 84863004089     PISSN: 00211265     EISSN: 18634362     Source Type: Journal    
DOI: 10.1007/s11845-011-0760-y     Document Type: Article

References (18)

1. Bernstein CN, Shanahan F (2008) Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel disorders. Gut 57:1185-1191
2. Rampton DS, Shanahan F (2008) Fast facts: inflammatory bowel disease, 3rd edn. Health Press Limited, Oxford
3. Targan S, Shanahan F, Karp LC (2010) Inflammatory bowel disease: translating basic science into clinical practice. Wiley-Blackwell, Chichester
4. Strange EF, Travis SPL, Vermeire S et al (2008) European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohn's Colitis 2:1-23 (Pubitemid 351179487)
5. Travis SPL, Strange EF, Lemann M et al (2008) European evidence-based consensus on the management of ulcerative colitis: current management. J Crohn's Colitis 2:24-62 (Pubitemid 351179488)
6. Hoie O, Wolters FL, Riis L et al (2007) Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology 132:507-515
7. Henrikson M, Jahnson J, Lygren I et al (2006) Ulcerative colitis and clinical course: results of a 5-year population based follow-up study (the IBSEN study). Inflamm Bowel Dis 12:543-550 (Pubitemid 43977734)
8. Langholtz E, Munkholm P, Nielson OH, Kreiner S, Binder V (1991) Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol 26:1247-1256
9. Dinesen LC, Walsh AJ, Nedeljkovic-Protic M et al (2010) The pattern and outcome of acute severe colitis. J Crohn's Colitis 4:431-437
10. Aratari A, Papi C, Clemente V et al (2008) Colectomy rate in acute severe ulcerative colitis in the infliximab era. Dig Liver Dis 40:821-826
11. Robinson A, Thompson G, Wilkin D et al (2001) Guided self-management and patient directed follow-up of ulcerative colitis: a randomised trial. Lancet 358:976-981 (Pubitemid 32913524)
12. Robinson A (2004) Review article: inflammatory bowel disease-empowering the patient and improving outcome. Aliment Pharm Ther 20(suppl 4):84-87 (Pubitemid 39319253)
13. Ho GT, Chiam P, Drummond H, Loane J, Arnott IDR, Satsangi J (2006) The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort. Aliment Pharmacol Ther 24:319-330 (Pubitemid 43972900)
14. Jakobsen C, Munkholm P, Paerregaard A, Wewer V (2011) Steroid dependency and pediatric inflammatory bowel disease in the era of immunomodulators-a population-based study. Inflamm Bowel Dis 17:1731-1740
15. Faubion WA Jr, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Sandborn WJ (2001) The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 121:255-260 (Pubitemid 32729372)
16. Teml A, Schaeffeler E, Herrlinger KR, Klotz U, Schwab M (2007) Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing. Clin Pharmacokinet 46:187-208 (Pubitemid 46425646)
17. Kim DU, Kim YH, Kim BJ et al (2009) The efficacy of low dose azathioprine/6-mercaptopurine in patients with inflammatory bowel disease. Hepatogastroenterology 56:1395-1402
18. Scribano ML (2008) Adverse events of IBD therapies. Inflamm Bowel Dis 14(suppl 2):S210-S211